CA-DENODO
9.6.2022 09:02:06 CEST | Business Wire | Press release
Denodo , a leader in data management, today released the findings of its sixth annual cloud usage survey which revealed that cloud adoption is continuing its rapid climb, with more than half (54%) of participants stating they are either at an intermediate or advanced level of cloud usage. Cloud-enabled business transformation has become a priority as organizations face global supply chain issues, cybersecurity threats, and geopolitical instability. While organizations of all sizes and vertical markets are turning to the cloud to ensure flexibility and resilience in the face of these challenges, small to medium sized businesses have driven investment in cloud infrastructure services to support workload migration, data storage services, and cloud-native application development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220607006385/en/
Download the complimentary findings here .
Cloud-based data warehouses, data lakes, and lake houses played a prominent role in 2021, and was cited as both a top initiative by respondents (48%) and a top use case (57%). Hybrid cloud continues to be the deployment model of choice as it has been since the 2020 survey. However, this year, the gap between hybrid cloud and private cloud is dramatically wider. Hybrid cloud was chosen by almost twice the number of respondents (37.5%), compared with pure public cloud, at 20%. This year, it is clear that hybrid cloud is less a “choice” but a “necessity” and indicates that companies are not completely getting rid of their on-premises systems even if they have increased their cloud footprint. Companies have good reasons for deploying this mixed deployment style, regulatory compliance among them, which may be why they are opting not to simply abandon on-premises systems when the technology landscape changes.
As it relates to these survey respondent companies being data-driven, nearly four in five respondents (79%) cited complexity of data integration, data accessibility, and accommodating different data formats as the primary barrier to becoming data-driven followed by the lack of analytical skills and resources to turn raw data into insights (62%). Data scientists struggled as well. Often cited for spending more time finding, accessing, and preparing data than they do analyzing it, more than 2 out of five (44%) were unable to find, access, and analyze half or more of their data after adopting cloud technologies and only 17% were able to leverage 75% or more of their data.
The role of IT in the cloud modernization journey has also changed. In 2020, the focus for tech professionals was choosing the appropriate cloud provider and managing the migration. But in 2021, these IT teams are more focused on receiving the training needed to take their organization’s cloud systems to the next level (as per 31.3% of survey respondents), while other activities such as selecting cloud provider and planning for cloud migrations still remain important. Companies are using cloud for various use cases with the most popular being reporting and dashboards, and self-service BI and ad-hoc analytics; however, respondents anticipate a shift to data virtualization, data preparation, data quality and blending in the future.
These use cases paint a vivid portrait of where many organizations are with respect to their cloud journeys. First, it reflects the fact that the business stakeholders within organizations are ready to get better use out of their data, and second, it shows that organizations are now looking to maximize their cloud systems with robust cloud-based repositories. Having migrated key workloads to the cloud, the next step for many companies is to find a place to store the new data they then begin to acquire. Modern data-management approaches like logical data fabric enable organizations to seamlessly accommodate legacy systems so that they can work in tandem with cloud systems.
“Audiences continue to express their need for real-time data so it is no surprise that availability, with regard to data integration, management, and analytics in the cloud, is not only ‘nice to have,’ but critical to becoming data-driven,” said Ravi Shankar, senior vice president and chief marketing officer of Denodo. “This is true across all configurations, but the reality is most organizations are unable to find, access, and analyze half or more of their data after adopting cloud technologies. That may be why the overwhelming majority of organizations (93%) stated that they were using, evaluating, or considering leveraging cloud-based data integration, management, and analytics including powerful technologies, such as data virtualization and logical data fabric to provide seamless, real-time access across both on-premises and cloud systems.”
When it comes to choosing cloud service providers, Microsoft Azure and Amazon Web Services (AWS) continue to dominate the market by a wide margin, but this year, AWS (44.6%) has jumped ahead of Azure (26.2%) with a substantial lead, after Azure has kept just ahead of AWS for two consecutive years. Google Cloud Platform (GCP) came in as a third most popular option (8%), according to the survey. In contrast, Alibaba showed a bump from 1.4% in 2021 to 3.6% this year.
Methodology:
The Denodo Global Cloud Survey 2022 surveyed stakeholders at over 150 organizations across 3 major global regions – North America, EMEA, and APAC – to understand where organizations are in their cloud adoption journeys. Surveys were fielded online to data and cloud professionals from various backgrounds and roles in March of 2022. The results from the Denodo Global Cloud Survey 2022 are available for download here .
Please Tweet: https://bit.ly/3Nt7uZ1
About Denodo
Denodo is a leader in data management. The award-winning Denodo Platform is the leading data integration, management, and delivery platform using a logical approach to enable self-service BI, data science, hybrid/multi-cloud data integration, and enterprise data services. Realizing more than 400% ROI and millions of dollars in benefits, Denodo’s customers across large enterprises and mid-market companies in 30+ industries have received payback in less than 6 months. For more information, visit www.denodo.com or call +1 877 556 2531 / +44 (0) 20 7869 8053 / +65 6950 7489.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220607006385/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom